"The big three" infections 'AIDS, TB and malaria' have caught the world's attention but other disabling and fatal infectious diseases in Africa, which affect millions of people a year, are being ignored, say three eminent tropical disease researchers in the international health journal PLoS Medicine.
The researchers, led by Professor David Molyneux, Director of the Lymphatic Filariasis Support Centre at the Liverpool School of Tropical Medicine, argue that a "rapid impact package - distribution of four anti-parasitic drugs across Africa to treat seven neglected diseases" would bring tangible benefits to the world's poorest communities.
The neglected tropical diseases, which include sleeping sickness, schistosomiasis, river blindness, hookworm, elephantiasis, and blinding trachoma, affect several hundred million people, and kill at least half a million annually, and yet they garner little attention from donors, policymakers, and public health officials.
The cost of the package, they say, would be negligible "a mere 25 pence per person per year, compared with a minimum of around £120 per person per year to treat HIV/AIDS, £120 per person to treat a single episode of TB, and around £4 to treat a single episode of malaria."
Three of the drugs in the package (ivermectin, azithromycin, and albendazole) are being donated by their manufacturers, and the fourth (praziquantel) now costs only a few pence per tablet.
Professor Molyneux and his colleagues, Professor Peter Hotez of the Human Hookworm Initiative and Professor Alan Fenwick of the Schistosomiasis Control Initiative, argue that a rapid impact package against some of the neglected tropical diseases could permanently reduce their incidence.
For costs that are relatively modest compared to controlling "the big three," an integrated control package for neglected tropical diseases could have a proportionately greater impact on more poor people¹s health as well as being more equitable for the majority of Africa 's poorest and marginalised communities.
Range of Treatment Costs Per Year for Treating HIV/AIDS, TB, Malaria, and Neglected Tropical Diseases ("Rapid Impact Package")
The researchers "urge policy makers and health economists to recognize that although HIV, TB, and malaria are the most serious problems facing health planners, other diseases exist that can be addressed at realistic costs with effective interventions."
"Controlling Africa¹s neglected diseases is one of the more convincing ways to 'make poverty history' through affordable, pro-poor, effective, and tested strategies."
All works published in PLoS Medicine are open access. Everything is immediately available without cost to anyone, anywhere ' to read, download, redistribute, include in databases, and otherwise use' subject only to the condition that the original authorship is properly attributed. Copyright is retained by the authors. The Public Library of Science uses the Creative Commons Attribution License.
Citation: Molyneux DH, Hotez PJ, Fenwick A (2005) "Rapid-impact interventions": How a policy of integrated control for Africa's neglected tropical diseases could benefit the poor. PLoS Med 2(11): e336.
Link To The Published Article:
Professor David H Molyneux
Liverpool School of Tropical Medicine
Lymphatic Filariasis Support Centre
Liverpool , L3 5QA
Mobile/Cell phone : +44 (0)77-8099-1824